Novartis (NVS) 2026 Earnings Outlook: Risks & Opportunities
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
Adjusting your budget mid month can help you stay on track with your financial goals. Discover the best times to make these changes.
23,727 articlesNovartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
Oil-driven moves lift lucid (lcid) rivian (rivn) shares, while tesla (tsla) faces regulatory scrutiny and BYD competi...
As XRP weathered a months-long retreat, new regulatory wins, steady ETF inflows, and surging on-chain activity are fu...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...
Retail investors flocked to private credit for high yields, but a sudden liquidity crunch has turned a stellar run in...
Bitcoin surged past $74,000 as institutional buying returned to the market, sparking a wider crypto rally. Investors ...
Bitcoin sits near a critical level around $73,500 ahead of the March FOMC decision, with investors parsing policy sig...
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Toncoin and MemeCore surged roughly 30% as Bitcoin touched $81,000, signaling renewed trader interest amid a choppy m...